NCT04774718 2026-04-06A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS TumorsHoffmann-La RochePhase 1/2 Recruiting42 enrolled
NCT02521051 2025-05-13Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung CancerMassachusetts General HospitalPhase 1/2 Terminated11 enrolled 21 charts